Font Size:
a
A
A
Keyword [Diffuse large B cell lymphoma(DLBCL)]
Result: 41 - 48 | Page: 3 of 3
41.
Clinical Characteristics And Prognostic Value Analysis Of DLBCL Patients With TP53 Gene Variation Detected By Next Generation Sequencing And FISH
42.
Application Of Circulating Tumor DNA In Diffuse Large B-cell Lymphoma
43.
Expression And Role Of Mir-525-5p And MyD88/NF-κB Regulatory Pathway In Diffuse Large B Cell Lymphoma
44.
Study On The Mechanism And Drug Sensitivity Of Hsa-miR-28-5p/YWHAZ Axis In Diffuse Large B Cell Lymphoma
45.
The Exploratory Research In Vitro Of DLBCL Treatment Through PI3K Inhibitor YY-20394
46.
Expression And Significance Of APOC1、APOE Protein In Diffuse Large B-cell Lymphoma
47.
Relationship Between Immune Checkpoint Expression And Pathological Features And Prognosis In The Immune Microenvironment Of Diffuse Large B-cell Lymphoma
48.
Impact Of Diagnosis-to-Treatment-Interval And Treatment-Delay-Time On Outcomes Of Patients With Diffuse Large B-cell Lymphoma
<<First
<Prev
Next>
Last>>
Jump to